SHIRLEY, N.Y. , Oct.
29, 2024 /PRNewswire/ -- American Regent announces the launch of 30 mL Epinephrine Injection, USP. 1 Epinephrine Injection, USP is indicated for emergency treatment of allergic reactions (Type I), including anaphylaxis, which may result from insect stings or bites, foods, drugs, sera, diagnostic testing substances, and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. Epinephrine is also indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.
"With the approval of Epinephrine Injection, USP we continue to show our commitment to ensuring both patients and providers have access to high-quality treatment options," stated Joann Gioia , Vice President and Chief Commercial Officer at American Regent, Inc. Product is available for immediate shipment. Customers can order Epinephrine Injection, USP through their wholesaler/distributor or by contacting our Customer Support Group at 1-800-645-1706 .
Epinephrine Injection, USP is supplied as follows: Please see the accompanying Important Safety Information in addition to the Full Prescribing Information . For additional information, please visit americanregent.com .
REFERENCE : 1. Epinephrine Injection, USP. Package insert.
American Regent, Inc. © 2024 American Regent, Inc. All rights reserved.
PP-EP-US-0024 5 Ramsey Road, Shirley, NY 11747 \ 1.800.645.
1706 F 631.924.1731 \ www.
americanregent.com A Daiichi Sankyo Group Co.